BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:52 PM
 | 
Mar 18, 2010
 |  BC Extra  |  Company News

Roche gives R&D update

At its investor day on Thursday, Roche (SIX:ROG; OTCQX:RHHBY) said it hopes to file for regulatory approval of up to 35 line extensions for existing products and 16 NMEs by 2014. The company also expects up to 13 NMEs to enter late stage trials this year. However, CEO Severin...

Read the full 230 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >